---
figid: PMC6423768__12943_2019_981_Fig7_HTML
figtitle: A schematic diagram of exosomal miR-128-3p based signaling pathway in CRC
  treatment
organisms:
- Homo sapiens
- Mus musculus
- Moloney murine leukemia virus
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC6423768
filename: 12943_2019_981_Fig7_HTML.jpg
figlink: /pmc/articles/PMC6423768/figure/Fig7/
number: F7
caption: A schematic diagram of exosomal miR-128-3p based signaling pathway in CRC
  treatment. In oxaliplatin-resistant CRC cells, exosomal miR-128-3p derived from
  FHC-128 cells reverse oxaliplatin resistance by competitively binding Bmi1 and MRP5,
  leading to the increased expression of E-cadherin (suppress EMT phenotype) and reduced
  the oxaliplatin efflux
papertitle: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant
  colorectal cancer.
reftext: Tong Liu, et al. Mol Cancer. 2019;18:43.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9359408
figid_alias: PMC6423768__F7
figtype: Figure
redirect_from: /figures/PMC6423768__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6423768__12943_2019_981_Fig7_HTML.html
  '@type': Dataset
  description: A schematic diagram of exosomal miR-128-3p based signaling pathway
    in CRC treatment. In oxaliplatin-resistant CRC cells, exosomal miR-128-3p derived
    from FHC-128 cells reverse oxaliplatin resistance by competitively binding Bmi1
    and MRP5, leading to the increased expression of E-cadherin (suppress EMT phenotype)
    and reduced the oxaliplatin efflux
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BMI1
  - COMMD3-BMI1
  - TWIST1
  - ABCC5
  - CDH1
  - FZR1
  - EZH2
  - FTH1
  - LDLR
  - MYBPC3
  - Bmi1
  - Twist1
  - Abcc5
  - Ighv9-4
  - Cdh1
  - Fzr1
  - Ezh2
  - Fth1
  - bmi1a
  - twist1a
  - cdh1
  - si:busm1-180o5.1
  - si:busm1-180o5.2
  - ezh2
  - Oxaliplatin
  - FHC
---
